Related Articles
Elevated tumor mutation burden and immunogenic activity in patients with hormone receptor‑negative or human epidermal growth factor receptor 2‑positive breast cancer
Somatic mutations in genes associated with mismatch repair predict survival in patients with metastatic cancer receiving immune checkpoint inhibitors
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
Mismatch repair proteins expression and tumor‑infiltrating T‑cells in colorectal cancer
Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review)